AstraZeneca looking at outsider CFO

AstraZeneca wants some fresh eyes on its financial challenges. The drug maker is casting outside of pharma for a new CFO to replace Jon Symonds, who quit abruptly in June to join Goldman Sachs.

The company is down to a short list and expects to announce the chosen one soon. That'll be two down and five to go; Pfizer recently tapped an industry outsider as its new CFO, and five other drug companies are still on the hunt.

- read this article from the Financial Times

Related Articles:
Finance chiefs fleeing from biopharmas. Report
AstraZeneca cuts 7,600 jobs. Report
AstraZeneca announces restructuring and buyout. Report
AstraZeneca to continue ambitious deal-making. Report
AstraZeneca lays out road map for recovery. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.